Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01548430 · ClinicalTrials.gov registry record · Phase 1
A Safety Study of TTP4000 in Subjects With Alzheimer's Disease
A Phase 1 study, sponsored by vTv Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT01548430 is a Phase 1 study that has completed, run by vTv Therapeutics. The registered enrollment target is 8 participants.
The verdict
NCT01548430, a Phase 1 study, has completed, sponsored by vTv Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of the study is to examine the safety, tolerability, immunogenicity and pharmacokinetics of TTP4000 in subjects with Alzheimer's disease with mild cognitive impairment.
Interventions
- DRUG Placebo
- DRUG TTP4000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01548430
The ClinicalTrials.gov registry entry for NCT01548430 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is vTv Therapeutics, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01548430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01548430 about?
NCT01548430 is a clinical study titled "A Safety Study of TTP4000 in Subjects With Alzheimer's Disease". The purpose of the study is to examine the safety, tolerability, immunogenicity and pharmacokinetics of TTP4000 in subjects with Alzheimer's disease with mild cognitive impairment.
What is the current status of trial NCT01548430?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2011-10. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01548430?
The interventions under investigation include: Placebo (DRUG), TTP4000 (DRUG).
Who is sponsoring clinical trial NCT01548430?
This trial is sponsored by vTv Therapeutics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.